#Japan #Fukuoka #STAAR Surgical #Senshinkai #ICL Surgery

A Game Changer in Vision Correction

In a groundbreaking announcement, Senshinkai Medical Corporation, led by Dr. Yoshitaka Oka, has revealed plans to revise the pricing structure for ICL (Intraocular Collamer Lens) surgery, making it available at unprecedented low rates beginning September 1, 2025. With a mission statement that declares, "Together with you, we can experience the joy of vision," this initiative aims to ease the financial burden many face when considering eye correction treatments.

Understanding ICL Surgery

ICL surgery is a procedure that involves implanting a small lens inside the eye to correct refractive errors such as myopia, astigmatism, and hyperopia. This procedure has been endorsed by Japan’s Ministry of Health, Labour, and Welfare as a highly reliable method, confirming its safety and effectiveness. In partnership with STAAR Surgical, a leading provider of ICL products, Senshinkai is dedicated to promoting safe and healthy ICL treatments across Japan.

With over 27,000 cases performed from November 2002 to September 2024, the clinic boasts extensive experience in refractive surgeries, maintaining a strong reputation for its commitment to patient care and innovative medical practices.

Background Behind the New Pricing

Despite the numerous inquiries and consultations, one consistent feedback has surfaced: many individuals express a desire to undergo treatment but feel deterred by financial concerns. Recognizing that regaining or improving vision can significantly enhance one’s quality of life, the medical team's leadership took these concerns seriously.

Under the guiding principle of “Together with you, we can experience the joy of vision,” Senshinkai has engaged in comprehensive cost-cutting measures and digital transformation initiatives to adjust the fundamental price of ICL surgery to align with the lowest in the industry. Starting on September 1, 2025, this new pricing model will be implemented, prioritizing accessibility for patients while maintaining high-quality care.

Senshinkai Medical Corporation: A Nationwide Vision Care Provider

Operating clinics in major cities such as Tokyo, Nagoya, Osaka, and Fukuoka, Senshinkai Medical Corporation offers a wide range of eye care treatments beyond ICL and LASIK surgeries, including presbyopia treatment and laser cataract surgeries. The organization continues to strive for excellence in patient satisfaction through personalized care and support.

From post-operative follow-ups to minimize discomfort to convenient booking systems via web and mobile platforms, Senshinkai aims to be a lifelong partner in vision for each patient. The clinic not only focuses on reducing procedural pain with advanced anesthesia techniques but also ensures open lines of communication between patients and staff through chat services.

Company Overview

• - Company Name: Senshinkai Medical Corporation
• - Location: 364-2 Kawazu, Iizuka City, Fukuoka Prefecture
• - Representative: Dr. Yoshitaka Oka
• - Established: November 2002
• - Services: ICL and LASIK eye surgery, presbyopia, and cataract surgeries
• - Locations: Tokyo, Nagoya, Osaka, Fukuoka
• - Website: https://senshinkai-clinic.jp/

As the medical community moves towards more accessible health services, Senshinkai Medical Corporation sets a positive precedent with its innovative pricing strategies, aiming to ensure that everyone has the opportunity to experience the benefits of improved vision.